PHYSIOLOGY OF WATER BALANCE--RESEARCH AND EDUCATION PROJECT
PHYSIOLOGY OF WATER BALANCE--RESEARCH AND EDUCATION PROJECT
批准号:
6263950
负责人:
GARY L. ROBERTSON
金额:
$2.05万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30
中文摘要
在世界各地的几乎所有医学领域,溶质和水平衡失调都是导致发病率和死亡率的重要原因。因此,水和溶质动态平衡的生理学和病理生理学的实用知识对每个执业医生来说都是必不可少的。控制人类体内溶质和水平衡的主要因素是众所周知的。其中一些机制,如调节肾脏水分和溶质排泄的机制,已经在细胞水平和全身水平得到了广泛的研究。然而,人们对其他重要变量的调节知之甚少,例如摄入量或肾外排出量。在正常活动期间或在患者经常接受研究和治疗的情况下,关于调节系统的各个部分如何相互作用以维持健康人的水分和溶质平衡的可靠信息甚至更少。在这方面尤其缺乏关于个人之间以及不同年龄、性别、族裔或种族群体之间正常差异的范围和原因的可靠数据。例如,很明显,无论男女,健康的年轻高加索成年人在口渴的渗透调节和抗利尿激素精氨酸加压素(1)的分泌方面都表现出非常大的、由基因决定的个体间差异,但尚不清楚这些差异如何转化为总体水分和溶质动态平衡的个体差异。关于成人尿量正常变化的最佳可用信息(2)显示范围为600至1600毫升/24小时,但这些值与性别、种族、环境条件或身体大小或溶质负荷的变化无关。此外,这个正常范围的有效性是高度可疑的,因为最近对CRC(3,4)中12名健康的年轻成年志愿者的研究显示,其中25%的人的尿量在1800至3600毫升/24小时之间。显然,确定这种差异是由于早期研究中的错误方法、我们自己研究中的住院或选择偏差,还是仅仅是过去50年来饮食习惯的文化变化,这一点很重要。类似的不确定性也与已公布的尿溶质排泄、液体摄入量和无意识水分丢失的正常值有关,这些正常值也必须因遗传和环境因素而在人与人之间显著变化。需要澄清这些问题,以便为区分个体患者的疾病和正常变异提供更合理的基础。
英文摘要
Disorders of solute and water balance are a significant cause of morbidity and mortality in virtually all areas of medicine in every part of the world. Thus, a working knowledge of the physiology and pathophysiology of water and solute homeostasis is essential for every practicing physician. The principal elements in the control of solute and water balance in humans are well known. Some of them, such as the mechanisms that regulate the renal excretion of water and solute, have been studied extensively at the level of the cell as well as the whole body. However, much less is known about the regulation of other important variables such as intake or extrarenal output. There is even less reliable information about the way the various parts of the regulatory system interact to maintain water and solute balance in healthy people during normal activities or under the conditions in which patients are often studied and treated. Particularly lacking in this regard are reliable data concerning the scope and causes of normal variation between individuals as well as between different age, gender, ethnic or racial groups. It is clear, for example, that healthy young caucasian adults of both sexes show very large, genetically determined inter-individual differences in the osmoregulation of both thirst and secretion of the antidiuretic hormone, arginine vasopressin (1) but it is not known how these differences translate into individual variation in overall water and solute homeostasis. The best available information on normal variation in urine volume in adults (2) indicates a range from 600 to 1600 ml/24 hours but does not relate these values to gender, race, environmental conditions or variations in body size or solute load. Moreover, the validity of this normal range is highly dubious because a recent study of 12 healthy young adult volunteers in the CRC (3,4)revealed that 25% of them had urine outputs between 1800 and 3600 ml/24hours. Clearly, it is important to determine if this discrepency is due to faulty methodology in the earlier study, to hospitalization or selection bias in our own study or simply to cultural changes in eating and drinking habits in the last 50 years. Similar uncertainties pertain to the published normal values for urinary solute excretion, fluid intake and insensible water loss which must also vary markedly from person to person depending on genetic and environmental factors. Clarification of these issues is needed to provide a more rational foundation for differentiating disease from normal variation in individual patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effect of the Oral Vasopressin Receptor Antagonist CI-1025
-
批准号:7040349
-
项目类别:
-
资助金额:$0.59万
-
财政年份:2003
-
负责人:GARY L. ROBERTSON
-
依托单位:
PATHOGENESIS AND PATHOPHYSIOLOGY OF FAMILIAL NEUROHYPOPHYSEAL DIABETES
-
批准号:6304172
-
项目类别:
-
资助金额:$2.05万
-
财政年份:1999
-
负责人:GARY L. ROBERTSON
-
依托单位:
EFFECTS OF VPA 985 AND PLACEBO IN TREATMENT OF HYPONATREMIA
-
批准号:6304152
-
项目类别:
-
资助金额:$2.05万
-
财政年份:1999
-
负责人:GARY L. ROBERTSON
-
依托单位:
PHENOTYPE AND GENOTYPE IN CONGENITAL NEPHROGENIC DIABETES INSIPIDUS
-
批准号:6304185
-
项目类别:
-
资助金额:$2.05万
-
财政年份:1999
-
负责人:GARY L. ROBERTSON
-
依托单位:
PHENOTYPE AND GENOTYPE IN CONGENITAL NEPHROGENIC DIABETES INSIPIDUS
-
批准号:6114046
-
项目类别:
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:GARY L. ROBERTSON
-
依托单位:
PATHOGENESIS AND PATHOPHYSIOLOGY OF FAMILIAL NEUROHYPOPHYSEAL DIABETES
-
批准号:6114056
-
项目类别:
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:GARY L. ROBERTSON
-
依托单位:
NOVEL TYPES OF FAMILIAL DIABETES INSIPIDUS
-
批准号:6114057
-
项目类别:
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:GARY L. ROBERTSON
-
依托单位:
EFFECTS OF VPA 985 AND PLACEBO IN TREATMENT OF HYPONATREMIA
-
批准号:6263962
-
项目类别:
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:GARY L. ROBERTSON
-
依托单位:
NOVEL TYPES OF FAMILIAL DIABETES INSIPIDUS
-
批准号:6275292
-
项目类别:
-
资助金额:$2.26万
-
财政年份:1997
-
负责人:GARY L. ROBERTSON
-
依托单位:
PATHOGENESIS AND PATHOPHYSIOLOGY OF FAMILIAL NEUROHYPOPHYSEAL DIABETES
-
批准号:6245171
-
项目类别:
-
资助金额:$1.2万
-
财政年份:1997
-
负责人:GARY L. ROBERTSON
-
依托单位:
PHENOTYPE AND GENOTYPE IN CONGENITAL NEPHROGENIC DIABETES INSIPIDUS
-
批准号:6245151
-
项目类别:
-
资助金额:$1.2万
-
财政年份:1997
-
负责人:GARY L. ROBERTSON
-
依托单位:
PHENOTYPE AND GENOTYPE IN CONGENITAL NEPHROGENIC DIABETES INSIPIDUS
-
批准号:6275281
-
项目类别:
-
资助金额:$2.26万
-
财政年份:1997
-
负责人:GARY L. ROBERTSON
-
依托单位:
PATHOGENESIS AND PATHOPHYSIOLOGY OF FAMILIAL NEUROHYPOPHYSEAL DIABETES
-
批准号:6275291
-
项目类别:
-
资助金额:$2.26万
-
财政年份:1997
-
负责人:GARY L. ROBERTSON
-
依托单位:
NOVEL TYPES OF FAMILIAL DIABETES INSIPIDUS
-
批准号:6245172
-
项目类别:
-
资助金额:$1.2万
-
财政年份:1997
-
负责人:GARY L. ROBERTSON
-
依托单位:
ENDOGENOUS OPIATES IN THE REGULATION OF VASOPRESSIN
-
批准号:3234883
-
项目类别:
-
资助金额:$16.18万
-
财政年份:1988
-
负责人:GARY L. ROBERTSON
-
依托单位:
ENDOGENOUS OPIATES IN THE REGULATION OF VASOPRESSIN
-
批准号:3234885
-
项目类别:
-
资助金额:$2.55万
-
财政年份:1988
-
负责人:GARY L. ROBERTSON
-
依托单位:
ENDOGENOUS OPIATES IN THE REGULATION OF VASOPRESSIN
-
批准号:3234882
-
项目类别:
-
资助金额:$17.67万
-
财政年份:1988
-
负责人:GARY L. ROBERTSON
-
依托单位:
ENDOGENOUS OPIATES IN THE REGULATION OF VASOPRESSIN
-
批准号:3234879
-
项目类别:
-
资助金额:$16.97万
-
财政年份:1988
-
负责人:GARY L. ROBERTSON
-
依托单位:
ENDOGENOUS OPIATES IN THE REGULATION OF VASOPRESSIN
-
批准号:3234881
-
项目类别:
-
资助金额:$16.41万
-
财政年份:1988
-
负责人:GARY L. ROBERTSON
-
依托单位:
ENDOGENOUS OPIATES IN THE REGULATION OF VASOPRESSIN
-
批准号:3234884
-
项目类别:
-
资助金额:$16.91万
-
财政年份:1988
-
负责人:GARY L. ROBERTSON
-
依托单位:
海外基金